SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
16-Sep-16 5:01 PM View: | Protalix BioTherapeutics, I... (PLX) | 15-Sep-16 | Option Exercise | 122,162 | $0.00 | $122.16 | 18% 673.75K to 795.92K | |
18-Jul-12 4:32 PM View: | Protalix BioTherapeutics, I... (PLX) | 16-Jul-12 | Grant | 210,000 | -- | -- | 45% 463.75K to 673.75K | |
04-May-12 5:14 PM View: | Protalix BioTherapeutics, I... (PLX) | 02-May-12 | Market Sale (Planned) | 300,000 | $7.13 | $2,139,000.00 | (39%) 763.75K to 463.75K | 93% |
09-Aug-10 5:00 PM View: | Protalix BioTherapeutics, I... (PLX) | 06-Aug-10 | Market Sale (Planned) | 4,619 | $7.00 | $32,333.00 | (< 1%) 768.37K to 763.75K | 93% |
09-Aug-10 5:00 PM View: | Protalix BioTherapeutics, I... (PLX) | 05-Aug-10 | Market Sale (Planned) | 48,408 | $7.00 | $338,856.00 | (6%) 816.78K to 768.37K | 93% |
23-Jun-10 6:12 PM View: | Protalix BioTherapeutics, I... (PLX) | 21-Jun-10 | Market Sale (Planned) | 52,973 | $7.00 | $370,811.00 | (6%) 869.75K to 816.78K | 93% |
03-May-10 4:36 PM View: | Protalix BioTherapeutics, I... (PLX) | 29-Apr-10 | Market Sale (Planned) | 12,691 | $7.00 | $88,837.00 | (1%) 882.45K to 869.75K | 93% |
16-Apr-10 5:27 PM View: | Protalix BioTherapeutics, I... (PLX) | 14-Apr-10 | Market Sale (Planned) | 1,309 | $7.00 | $9,163.00 | (< 1%) 883.75K to 882.45K | 93% |
25-Mar-10 9:11 PM View: | Protalix BioTherapeutics, I... (PLX) | 25-Mar-10 | Market Sale (Planned) | 50,000 | $7.00 | $350,000.00 | (5%) 933.75K to 883.75K | 93% |
25-Mar-10 9:11 PM View: | Protalix BioTherapeutics, I... (PLX) | 24-Mar-10 | Market Sale (Planned) | 202,700 | $7.08 | $1,435,120.00 | (18%) 1.14M to 933.75K | 93% |
25-Mar-10 9:11 PM View: | Protalix BioTherapeutics, I... (PLX) | 23-Mar-10 | Market Sale (Planned) | 127,300 | $7.02 | $893,646.00 | (10%) 1.26M to 1.14M | 93% |
19-Oct-09 8:44 PM View: | Protalix BioTherapeutics, I... (PLX) | 19-Oct-09 | Market Sale (Planned) | 43,120 | $9.43 | $406,622.00 | (3%) 1.31M to 1.26M | 94% |
19-Oct-09 8:44 PM View: | Protalix BioTherapeutics, I... (PLX) | 16-Oct-09 | Market Sale (Planned) | 25,680 | $9.39 | $241,135.00 | (2%) 1.33M to 1.31M | 94% |
19-Oct-09 8:44 PM View: | Protalix BioTherapeutics, I... (PLX) | 15-Oct-09 | Market Sale (Planned) | 31,200 | $9.39 | $292,968.00 | (2%) 1.36M to 1.33M | 94% |
08-Jul-09 5:00 PM View: | Protalix BioTherapeutics, I... (PLX) | 06-Jul-09 | Market Sale (Planned) | 100,000 | $5.09 | $509,400.00 | (7%) 1.46M to 1.36M | 90% |
20-May-09 6:00 PM View: | Protalix BioTherapeutics, I... (PLX) | 14-May-09 | Market Sale | 10,000 | $3.85 | $38,500.00 | (< 1%) 1.47M to 1.46M | 86% |
20-May-09 6:00 PM View: | Protalix BioTherapeutics, I... (PLX) | 13-May-09 | Market Sale | 20,000 | $3.51 | $70,200.00 | (1%) 1.49M to 1.47M | 85% |
13-Mar-09 7:16 PM View: | Protalix BioTherapeutics, I... (PLX) | 13-Mar-09 | Market Sale | 8,300 | $2.18 | $18,094.00 | (< 1%) 1.5M to 1.49M | 77% |
26-Dec-07 10:39 AM View: | Protalix BioTherapeutics, I... (PLX) | 19-Dec-07 | Market Purchase | 4,800 | $3.40 | $16,320.00 | < 1% 2.97M to 2.97M | (85%) |
26-Dec-07 10:39 AM View: | Protalix BioTherapeutics, I... (PLX) | 18-Dec-07 | Market Purchase | 5,100 | $3.40 | $17,335.00 | < 1% 2.96M to 2.97M | (85%) |
26-Dec-07 10:39 AM View: | Protalix BioTherapeutics, I... (PLX) | 17-Dec-07 | Market Purchase | 5,000 | $3.35 | $16,750.00 | < 1% 2.96M to 2.96M | (85%) |
12-Dec-07 2:02 PM View: | Protalix BioTherapeutics, I... (PLX) | 05-Dec-07 | Market Purchase | 15,100 | $3.14 | $47,388.00 | < 1% 2.94M to 2.96M | (84%) |
05-Jan-07 8:28 PM View: | Protalix BioTherapeutics, I... (PLX) | 31-Dec-06 | Grant | 2,944,110 | -- | -- | 100% 0 to 2.94M |